Pacira BioSciences, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Pacira BioSciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Pacira BioSciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$140M, a 887% decline year-over-year.
  • Pacira BioSciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$64.9M, a 245% decline year-over-year.
  • Pacira BioSciences, Inc. annual Operating Income (Loss) for 2023 was $87.7M, a 46.1% increase from 2022.
  • Pacira BioSciences, Inc. annual Operating Income (Loss) for 2022 was $60M, a 33.3% decline from 2021.
  • Pacira BioSciences, Inc. annual Operating Income (Loss) for 2021 was $89.9M, a 94% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$64.9M -$140M -$157M -887% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $92.3M $28.2M -$11.6M -29.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $104M $13.2M +$16.3M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $87.7M $33.2M +$43.1M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $44.6M $17.7M -$3.57M -16.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $48.2M $39.9M +$8.64M +27.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 $39.5M -$3.09M -$20.5M -118% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $60M -$9.89M -$14.1M -335% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $74.1M $21.3M -$10.1M -32.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $84.3M $31.2M -$3.61M -10.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $87.9M $17.4M -$2.04M -10.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $89.9M $4.21M -$14.6M -77.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $104M $31.4M +$13.8M +78.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $90.7M $34.8M +$42M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $48.7M $19.4M +$2.34M +13.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $46.4M $18.8M +$17.1M +996% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $29.3M $17.6M +$15.2M +630% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $14.1M -$7.15M -$12.4M -235% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $26.5M $17.1M +$16M +1484% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $10.5M $1.71M -$10.6M -86% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $21M $2.41M -$1.64M -40.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $22.7M $5.28M -$1.27M -19.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $23.9M $1.08M +$8.02M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $15.9M $12.3M +$3.8M +44.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $12.1M $4.05M +$7.62M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $4.5M $6.54M +$22.3M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$17.8M -$6.94M +$7.11M +50.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$24.9M $8.47M +$10.9M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 -$35.9M -$3.57M +$17.3M +82.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$53.2M -$15.8M -$9.34M -145% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 -$43.8M -$14.1M -$11.8M -523% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 -$32M -$2.46M -$1.65M -203% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$30.4M -$20.9M -$26M -508% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$4.4M -$6.44M -$8.26M -454% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $3.86M -$2.25M -$5.6M -167% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $9.46M -$813K +$4.35M +84.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $5.1M $5.11M +$6.09M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 -$991K $1.82M +$4.66M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$5.65M $3.34M +$12.6M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 -$18.3M -$5.17M +$4.66M +47.4% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 -$22.9M -$985K +$11.8M +92.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
Q2 2014 -$34.7M -$2.84M +$9.17M +76.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 -$43.9M -$9.26M +$9.39M +50.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-30
Q4 2013 -$53.3M -$9.82M +$6.01M +38% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-25
Q3 2013 -$59.3M -$12.8M +$2.89M +18.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-30
Q2 2013 -$62.2M -$12M -$5.38M -81.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 -$56.8M -$18.6M -$7.51M -67.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 -$49.3M -$15.8M -$1.11M -7.57% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 -$48.2M -$15.7M -$6.97M -79.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-31
Q2 2012 -$41.2M -$6.63M +$1.91M +22.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 -$43.1M -$11.1M -$4.02M -56.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 -$39.1M -$14.7M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 -$8.73M -$2.28M -35.4% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 -$8.53M -$2.9M -51.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$7.12M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$6.45M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 -$5.63M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.